Cargando…

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults

Depression and related neurobehavioral symptoms are common features of Alzheimer’s disease and other dementias. The presence of these potentially modifiable neurobehavioral symptoms in cognitively intact older adults may represent an early indication of pathophysiological processes in the brain. Tau...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, James R., Petersen, Melissa, Johnson, Leigh, O’Bryant, Sid E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603823/
https://www.ncbi.nlm.nih.gov/pubmed/34803857
http://dx.doi.org/10.3389/fpsyg.2021.774049
_version_ 1784601834627792896
author Hall, James R.
Petersen, Melissa
Johnson, Leigh
O’Bryant, Sid E.
author_facet Hall, James R.
Petersen, Melissa
Johnson, Leigh
O’Bryant, Sid E.
author_sort Hall, James R.
collection PubMed
description Depression and related neurobehavioral symptoms are common features of Alzheimer’s disease and other dementias. The presence of these potentially modifiable neurobehavioral symptoms in cognitively intact older adults may represent an early indication of pathophysiological processes in the brain. Tau pathology is a key feature of a number of dementias. A number of studies have found an association between tau and neurobehavioral symptoms. The current study investigated the relationship of a blood-based biomarker of tau and symptoms of depression, anxiety, worry, and sleep disturbances in 538 community based, cognitively normal older adults. Logistic regression revealed no significant relationship between plasma total tau and any measures of neurobehavioral symptoms. To assess the impact of level of tau on these relationships, participants were divided into those in the highest quintile of tau and those in the lower four quintiles. Regression analyses showed a significant relationship between level of plasma total tau and measures of depression, apathy, anxiety, worry and sleep. The presence of higher levels of plasma tau and elevated neurobehavioral symptoms may be an early indicator of cognitive decline and prodromal Alzheimer’s disease. Longitudinal research is needed to evaluate the impact of these factors on the development of dementia and may suggest areas for early intervention.
format Online
Article
Text
id pubmed-8603823
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86038232021-11-20 Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults Hall, James R. Petersen, Melissa Johnson, Leigh O’Bryant, Sid E. Front Psychol Psychology Depression and related neurobehavioral symptoms are common features of Alzheimer’s disease and other dementias. The presence of these potentially modifiable neurobehavioral symptoms in cognitively intact older adults may represent an early indication of pathophysiological processes in the brain. Tau pathology is a key feature of a number of dementias. A number of studies have found an association between tau and neurobehavioral symptoms. The current study investigated the relationship of a blood-based biomarker of tau and symptoms of depression, anxiety, worry, and sleep disturbances in 538 community based, cognitively normal older adults. Logistic regression revealed no significant relationship between plasma total tau and any measures of neurobehavioral symptoms. To assess the impact of level of tau on these relationships, participants were divided into those in the highest quintile of tau and those in the lower four quintiles. Regression analyses showed a significant relationship between level of plasma total tau and measures of depression, apathy, anxiety, worry and sleep. The presence of higher levels of plasma tau and elevated neurobehavioral symptoms may be an early indicator of cognitive decline and prodromal Alzheimer’s disease. Longitudinal research is needed to evaluate the impact of these factors on the development of dementia and may suggest areas for early intervention. Frontiers Media S.A. 2021-11-05 /pmc/articles/PMC8603823/ /pubmed/34803857 http://dx.doi.org/10.3389/fpsyg.2021.774049 Text en Copyright © 2021 Hall, Petersen, Johnson and O’Bryant. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Hall, James R.
Petersen, Melissa
Johnson, Leigh
O’Bryant, Sid E.
Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
title Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
title_full Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
title_fullStr Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
title_full_unstemmed Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
title_short Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
title_sort plasma total tau and neurobehavioral symptoms of cognitive decline in cognitively normal older adults
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603823/
https://www.ncbi.nlm.nih.gov/pubmed/34803857
http://dx.doi.org/10.3389/fpsyg.2021.774049
work_keys_str_mv AT halljamesr plasmatotaltauandneurobehavioralsymptomsofcognitivedeclineincognitivelynormalolderadults
AT petersenmelissa plasmatotaltauandneurobehavioralsymptomsofcognitivedeclineincognitivelynormalolderadults
AT johnsonleigh plasmatotaltauandneurobehavioralsymptomsofcognitivedeclineincognitivelynormalolderadults
AT obryantside plasmatotaltauandneurobehavioralsymptomsofcognitivedeclineincognitivelynormalolderadults